Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments

References

• Larsen SK, Gao Y, Basse PH. NK-cells in the tumor microenvironment. Crit Rev Oncog 2014; 19:91-105; PMID:24941376; http://dx.doi.org/10.1615/CritRevOncog.2014011142
   PubMedGoogle Scholar
• Stojanovic A, Cerwenka A. Natural killer cells and solid tumors. J Innate Immun 2011; 3:355-64; PMID:21502747; http://dx.doi.org/10.1159/000325465
   PubMed Web of Science ®Google Scholar
• Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, Shi M, Zhang H, Yang Y, Wu H et al. Functional impairment in circulating and intrahepatic NK-cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 2008; 129:428-37; PMID:18824414; http://dx.doi.org/10.1016/j.clim.2008.08.012
   PubMed Web of Science ®Google Scholar
• Wu Y, Kuang DM, Pan WD, Wan YL, Lao XM, Wang D, Li XF, Zheng L. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 2013; 57:1107-16; PMID:23225218; http://dx.doi.org/10.1002/hep.26192
   PubMed Web of Science ®Google Scholar
• Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998; 83:58-63; PMID:9655293; http://dx.doi.org/10.1002/(SICI)1097-0142(19980701)83:1%3c58::AID-CNCR8%3e3.0.CO;2-A
   PubMed Web of Science ®Google Scholar
• Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009; 50:799-807; PMID:19551844; http://dx.doi.org/10.1002/hep.23054
   PubMed Web of Science ®Google Scholar
• Marras F, Bozzano F, Ascierto ML, De Maria A. Baseline and dynamic expression of activating NK-cell receptors in the control of chronic viral infections: the paradigm of HIV-1 and HCV. Front Immunol 2014; 5:305; PMID:25071766; http://dx.doi.org/10.3389/fimmu.2014.00305
   PubMed Web of Science ®Google Scholar
• Cariani E, Missale G. KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma. Oncoimmunol 2013; 2:e26622; PMID:24501686; http://dx.doi.org/10.4161/onci.26622
   Google Scholar
• Peng YP, Zhu Y, Zhang JJ, Xu ZK, Qian ZY, Dai CC, Jiang KR, Wu JL, Gao WT, Li Q et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Transl Med 2013; 11:262; PMID:24138752; http://dx.doi.org/10.1186/1479-5876-11-262
   PubMed Web of Science ®Google Scholar
• Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Gonçalves A, André P, Romagné F, Thibault G et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK-cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
   PubMed Web of Science ®Google Scholar
• Kamimura H, Yamagiwa S, Tsuchiya A, Takamura M, Matsuda Y, Ohkoshi S, Inoue M, Wakai T, Shirai Y, Nomoto M et al. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence. J Hepatol 2012; 56:381-8; PMID:21756848; http://dx.doi.org/10.1016/j.jhep.2011.06.017
   PubMed Web of Science ®Google Scholar
• Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005; 43:1013-20; PMID:16168521; http://dx.doi.org/10.1016/j.jhep.2005.05.026
   PubMed Web of Science ®Google Scholar
• Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impari expression of NKG2D and T-cell activation. Nature 2002; 419:734-8; PMID:12384702; http://dx.doi.org/10.1038/nature01112
   PubMed Web of Science ®Google Scholar
• Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P, Zanetti A, Trenti T, Ferrari C, Missale G. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma. Clin Cancer Res 2013; 19:5465-73; PMID:23938290; http://dx.doi.org/10.1158/1078-0432.CCR-13-0986
   PubMed Web of Science ®Google Scholar
• Saha B, Szabo G. Innate immune cell networking in hepatitis C virus infection. J Leukoc Biol 2014; 96:757-66; PMID:25001860; http://dx.doi.org/10.1189/jlb.4MR0314-141R
   PubMed Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-38; PMID:10518312; http://dx.doi.org/10.1055/s-2007-1007122
   PubMed Web of Science ®Google Scholar
• Solana R, Campos C, Pera A, Tarazona R. Shaping of NK-cell subsets by aging. Curr Opin Immunol 2014; 29:56-61; PMID:24792889; http://dx.doi.org/10.1016/j.coi.2014.04.002
   PubMed Web of Science ®Google Scholar
• Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, Morgado S, Tarazona R, Solana R. Effect of age and CMV on NK-cell subpopulations. Exp Gerontol 2014; 54:130-7; PMID:24440462; http://dx.doi.org/10.1016/j.exger.2014.01.008
   PubMed Web of Science ®Google Scholar
• Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol 2004; 4:675-87; PMID:15343367; http://dx.doi.org/10.1038/nri1434
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother 2004; 53:865-78; PMID:15118842; http://dx.doi.org/10.1007/s00262-004-0521-0
   PubMed Web of Science ®Google Scholar
• Bossard C, Bézieau S, Matysiak-Budnik T, Volteau C, Laboisse CL, Jotereau F, Mosnier JF. HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int J Cancer 2012; 131:855-63; PMID:21953582; http://dx.doi.org/10.1002/ijc.26453
   PubMed Web of Science ®Google Scholar
• Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT et al. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunol Res 2014; 2:1209-19; PMID:25315249; http://dx.doi.org/10.1158/2326-6066.CIR-14-0096
   PubMed Web of Science ®Google Scholar
• El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O, Clouet-Delannoy M, Lombardelli L, Jabrane-Ferrat N, Rukavina D et al. Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK-cells in early pregnancy. J Immunol 2008; 181:3009-17; PMID:18713971; http://dx.doi.org/10.4049/jimmunol.181.5.3009
   PubMed Web of Science ®Google Scholar
• Elboim M, Gazit R, Gur C, Ghadially H, Betser-Cohen G, Mandelboim O. Tumor immunoediting by NKp46. J Immunol 2010; 184:5637-44; PMID:20404273; http://dx.doi.org/10.4049/jimmunol.0901644
   PubMed Web of Science ®Google Scholar